lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
1,057 rows where filing_year = 2015 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1655606 | O'NEILL, ATHY & CASEY, P.C. eb4baf6f-d0be-4717-8669-558f2aa082fa | Q1 | O'NEILL, ATHY & CASEY, P.C. | 42752 | COALITION OF BOSTON TEACHING HOSPITALS | 2015 | first_quarter | MED | Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH H.R. 1030/S. 544, Secret Science Reform Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-03-25T19:54:03.147000-04:00 | |
| 1655628 | O'NEILL, ATHY & CASEY, P.C. e5a55b10-d02d-4744-9e1d-7c2336fe13b5 | Q1 | O'NEILL, ATHY & CASEY, P.C. | 42752 | MASS GENERAL BRIGHAM | 2015 | first_quarter | MED | Funding for federally-sponsored medical research H.R. 531/S. 318, Accelerating Biomedical Research Act - provisions to provide stable funding to NIH H.R. 1030/S. 544, Secret Science Reform Act | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2015-03-25T20:21:12.997000-04:00 | |
| 1655725 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) b662ebff-9b1d-42a4-8509-a0f39313bd13 | Q1 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2015 | first_quarter | MED | Pharmaceutical labeling | Food & Drug Administration (FDA) | 18750 | 0 | 0 | 2015-04-01T09:51:03.867000-04:00 | |
| 1655798 | AMERICAN COLLEGE OF CLINICAL PHARMACY dc2e1c42-7138-4760-9870-6ed2ed91fe95 | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2015 | first_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 127250 | 0 | 0 | 2015-04-01T15:37:41.410000-04:00 | |
| 1655982 | ALZHEIMER'S FOUNDATION OF AMERICA 2f3d6baa-8dd4-4bc9-b82c-4d57d9a9226d | Q1 | ALZHEIMER'S FOUNDATION OF AMERICA | 323158 | ALZHEIMER'S FOUNDATION OF AMERICA | 2015 | first_quarter | MED | 21st Century Cures initiative | Administration on Aging,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 28000 | 0 | 0 | 2015-04-03T10:16:23.627000-04:00 | |
| 1656050 | HOLLAND & KNIGHT LLP f3e635e3-7c25-4bc6-af6c-ef112d3ac65f | Q1 | HOLLAND & KNIGHT LLP | 18466 | AMERICAN MEDICAL TECHNOLOGISTS | 2015 | first_quarter | MED | Payment and reimbursement for Medicare clinical laboratory testing; Medicare Part B reimbursement policies; Adjustments to Medicare Clinical Laboratory Fee Schedule; Affordable Care Act implementation; Regulation of laboratory-developed tests as medical devices by the Food and Drug Administration. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-03T13:39:25.623000-04:00 | |
| 1656106 | HOLLAND & KNIGHT LLP a36ec8e6-f512-4a8e-9c91-eee2022f4b38 | Q1 | HOLLAND & KNIGHT LLP | 18466 | PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | 2015 | first_quarter | MED | Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, The Sunscreen Innovation Act, the FY 2016 Ag-FDA Appropriations bill. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 90000 | 0 | 0 | 2015-04-03T15:23:14.223000-04:00 | |
| 1656178 | FRANCIS EDWARD & CRONIN, INC. 73475962-d451-4f80-9bbc-129edd2b50c5 | Q1 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2015 | first_quarter | MED | issues and legislation related to Alzheimer's disease research. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 10000 | 0 | 0 | 2015-04-04T13:47:29.637000-04:00 | |
| 1656238 | MARSHALL BRACHMAN ca0f2766-9d56-4bf5-8ab8-6a66acf5b049 | Q1 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2015 | first_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2015-04-04T19:00:13.210000-04:00 | |
| 1656524 | THE DLM GROUP c2b24212-386e-4e28-9c99-d03f4af302c2 | Q1 | THE DLM GROUP | 313794 | AVTEX COMMERCIAL PROPERTIES, INC. | 2015 | first_quarter | MED | Vaccine Technologies | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2015-04-06T16:24:36.623000-04:00 | ||
| 1656714 | MR. THEODORE (TED) JONES cee09d17-f986-40af-8149-76f5c13e0bc9 | Q1 | MR. THEODORE (TED) JONES | 20926 | COQUI RADIOPHARMACEUTICALS, CORP. | 2015 | first_quarter | MED | American Medical Isotopes Production Act of 2012 that was contained in the National Defense Authorization Act for Fiscal Year 2013. Acceleration of production of 99 MO using LEU (Low Enriched Uranium). | HOUSE OF REPRESENTATIVES,SENATE | 39193 | 0 | 0 | 2015-04-07T12:01:59.220000-04:00 | |
| 1657104 | DALRYMPLE & ASSOCIATES, LLC c85575ba-a02a-4484-8757-4d73fbb9af46 | Q1 | DALRYMPLE & ASSOCIATES, LLC | 5073 | SANOFI PASTEUR | 2015 | first_quarter | MED | Vaccine and immunization coverage. regulation, reimbursement, R&D and related issues | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE,White House Office | 46000 | 0 | 0 | 2015-04-08T10:15:03.117000-04:00 | |
| 1657149 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 0512f164-a4f3-4ba1-88c0-9af7eaddd532 | Q1 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2015 | first_quarter | MED | NIH budget including Title VII & VIII programs, Patient Trolling Technology transfer, Ebola Vaccine funding | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2015-04-08T11:16:42.680000-04:00 | |
| 1657201 | MERIDIAN HEALTH f16dbc62-0239-42d9-8141-a6d9624c3830 | Q1 | MERIDIAN HEALTH | 293313 | MERIDIAN HEALTH | 2015 | first_quarter | MED | National Institutes of Health appropriations Ebola funding Pandemic and hazards funding 340 (b) designation and funding Behavioral health funding | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 30000 | 0 | 0 | 2015-04-08T11:52:21.080000-04:00 | |
| 1657206 | WAKE FOREST UNIVERSITY HEALTH SCIENCES b015bb33-4957-44d1-8e92-5df3dff56611 | 1A | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2015 | first_quarter | MED | NIH budget including Title VII & VIII programs, Patient Trolling Technology transfer, Ebola Vaccine funding | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2015-04-08T11:52:22.457000-04:00 | |
| 1657231 | FEDERAL SOLUTIONS, LLC cc85ae51-bb27-452e-b541-6ecf20724a3c | Q1 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2015 | first_quarter | MED | Labor/HHS/Education Appropriation Bill 2015: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2015-04-08T12:21:39.177000-04:00 | |
| 1657254 | FEDERAL SOLUTIONS, LLC b12a69e0-ec2f-4c9b-87be-4ea430c7d5ee | Q1 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2015 | first_quarter | MED | Labor/HHS/Education Appropriations Bill 2015: Provisions relating to disease research, education and development. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-08T12:27:42.620000-04:00 | |
| 1657613 | POLICY DIRECTIONS INC. 318b4c53-4dc0-4a54-b7b7-aa0aef725d0a | Q1 | POLICY DIRECTIONS INC. | 31747 | CHARLES RIVER LABORATORIES | 2015 | first_quarter | MED | Pre-clinical research models and drug discovery, development and testing. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-09T10:27:55.253000-04:00 | |
| 1657630 | POLICY DIRECTIONS INC. 5a056450-cc26-45df-970b-b192f1a1ef0c | Q1 | POLICY DIRECTIONS INC. | 31747 | COVANCE INC | 2015 | first_quarter | MED | Medical and clinical research and testing issues and policies. 21st Century cures; FDA reform; clinical trials. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-09T10:52:05.250000-04:00 | |
| 1657928 | POLICY DIRECTIONS INC. 01e8c160-621a-426b-866d-287b6a7a6344 | Q1 | POLICY DIRECTIONS INC. | 31747 | ENTERA HEALTH, INC. | 2015 | first_quarter | MED | Guidance on Investigational New Drug; Overall industry standards | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-09T15:23:00.087000-04:00 | |
| 1658064 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 1d8b9ecf-b2df-4368-a3da-98e0786bd4b3 | Q1 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 3435 | AMERICAN SOCIETY FOR CLINICAL PATHOLOGY | 2015 | first_quarter | MED | Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule, Medicare Clinical Laboratory Fee Schedule; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shorages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease | Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office | 53500 | 0 | 0 | 2015-04-09T16:47:27.780000-04:00 | |
| 1658427 | DALRYMPLE & ASSOCIATES, LLC 16c26262-9427-452e-9872-12b8462f45d9 | 1A | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2015 | first_quarter | MED | Biodefense vaccines and therapeutic R&D and procurement Appropriations and Government Grant and Contract Funding | Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Logistics Agency,Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2015-04-10T12:57:57.780000-04:00 | |
| 1658435 | THE CJR GROUP, INC. 23272b6f-417b-43b1-9bd6-36d4328b8a51 | Q1 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2015 | first_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2015-04-10T13:05:00.363000-04:00 | |
| 1658512 | TCH GROUP, LLC 060c733e-2886-4fe1-a41b-c6b578f1c941 | Q1 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2015 | first_quarter | MED | Federal funding for AIDS vaccine research and development. Specifically, FY 16 State, Foreign Operations Appropriations bill | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-10T14:25:00.470000-04:00 | |
| 1658521 | PARRY, ROMANI, DECONCINI & SYMMS 958a0e23-6802-4501-a532-3f2b84e58116 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2015 | first_quarter | MED | Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. | HOUSE OF REPRESENTATIVES,SENATE | 32000 | 0 | 0 | 2015-04-10T14:31:08.897000-04:00 | |
| 1659366 | WILLIAMS AND JENSEN, PLLC 77577203-35de-432f-87e2-398d12318755 | Q1 | WILLIAMS AND JENSEN, PLLC | 41454 | BIOGEN IDEC | 2015 | first_quarter | MED | 21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-13T14:25:22.583000-04:00 | |
| 1659376 | WILLIAMS AND JENSEN, PLLC d36c5871-7beb-4f7d-8063-9303e8c76c84 | Q1 | WILLIAMS AND JENSEN, PLLC | 41454 | VERTEX PHARMACEUTICALS INCORPORATED | 2015 | first_quarter | MED | 21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-13T14:25:25.507000-04:00 | |
| 1659457 | NATIONAL COALITION FOR CANCER SURVIVORSHIP 0dfbf440-e5b8-4337-a362-ed5351f0532a | Q1 | NATIONAL COALITION FOR CANCER SURVIVORSHIP | 53276 | NATIONAL COALITION FOR CANCER SURVIVORSHIP | 2015 | first_quarter | MED | Legislation to improve functioning of FDA and NIH. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2015-04-13T15:02:22.180000-04:00 | ||
| 1659840 | INTUITIVE SURGICAL, INC. a38824a7-f8a5-4798-9a1b-a8251906f24e | Q1 | INTUITIVE SURGICAL, INC. | 400670004 | INTUITIVE SURGICAL, INC. | 2015 | first_quarter | MED | comparative effectiveness research in healthcare; medical research issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2015-04-13T20:10:01.287000-04:00 | |
| 1659908 | RAY C CULVER III ca89d2e6-e71c-48da-8c7d-747867905d50 | Q1 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2015 | first_quarter | MED | Funding for USDA Agricultural Research Service human nutrition research centers in the FY2016 Agricultural Appropriations bill. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-13T23:58:42.363000-04:00 | |
| 1659912 | THE PETRIZZO GROUP, INC. df564f49-19ea-426e-b569-7756602f35a9 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2015 | first_quarter | MED | Advocated for federal funding for research on traumatic brain injury, and PTSD. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-14T01:04:44.847000-04:00 | |
| 1660032 | MCDERMOTT+ LLC 449c9340-da2e-44f2-807e-c774b9fc2e70 | Q1 | MCDERMOTT+ LLC | 401103287 | CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION | 2015 | first_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 120000 | 0 | 0 | 2015-04-14T10:03:12.410000-04:00 | |
| 1660065 | MCDERMOTT+ LLC 582c5ca1-34b3-45e4-ad50-7dfa10fde269 | Q1 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2015 | first_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 90000 | 0 | 0 | 2015-04-14T10:15:25.723000-04:00 | |
| 1660125 | PERSONALIZED MEDICINE COALITION 818f709d-eec7-49df-9f8a-2340b98dc987 | Q1 | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2015 | first_quarter | MED | Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine, regulation of laboratory developed tests, 21st Century Cures Initiative | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-14T10:48:11.730000-04:00 | |
| 1660305 | LNE GROUP e6089add-c72b-4c16-85bb-da397328f4e2 | Q1 | LNE GROUP | 308811 | EP TECHNOLOGIES | 2015 | first_quarter | MED | Lobbied for Medical/ Disease Research/ Clinical Labs | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-14T11:49:32.237000-04:00 | |
| 1660455 | THE FRANKLIN PARTNERSHIP 1b41c96a-00fa-4e9d-b2dd-c03ee7e5d172 | Q1 | THE FRANKLIN PARTNERSHIP | 298091 | BARBARA ANN KARMANOS CANCER INSTITUTE | 2015 | first_quarter | MED | General advocacy for cancer research. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-14T13:37:38.653000-04:00 | |
| 1660511 | LNE GROUP 117232d5-e2dd-48ca-8cac-10ff0eef09f8 | Q1 | LNE GROUP | 308811 | SPR THERAPEUTICS | 2015 | first_quarter | MED | Lobbied for Medical/Disease Research/ and Clinical Labs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-14T14:06:16.527000-04:00 | |
| 1660546 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b13d81a9-834e-4644-a22a-0ec5a49df6a4 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2015 | first_quarter | MED | Appropriations & Authorization legislation for FY 2016 in health care Department of Defense Appropriations bill 2016 and Senate bill Military Construction and Veterans Affairs Appropriations bill FY 2016 and Senate bill | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2015-04-14T14:18:42.327000-04:00 | |
| 1660600 | FAEGRE DRINKER BIDDLE & REATH LLP 7908bd21-2ded-469a-9215-6f669e26676c | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | HARM REDUCTION COALITION | 2015 | first_quarter | MED | Overdose fatality prevention and education efforts and access to overdose rescue medication; Hepatitis C testing and prevention. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-14T14:33:26.697000-04:00 | |
| 1660643 | FAEGRE DRINKER BIDDLE & REATH LLP b68df200-f980-40cf-a586-41fe78405dcd | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC. | 2015 | first_quarter | MED | Reintroduction of the Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act; Cardiomyopathy Research Issues; Health Professional and Public Cardiomyopathy Education and Awareness Issues; Reintroduction of the Safe Play Act (S. 436/H.R. 436). | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-14T14:42:52.673000-04:00 | |
| 1660669 | FAEGRE DRINKER BIDDLE & REATH LLP 4cd9c1e8-a0a3-40b8-92bf-f914eae507db | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2015 | first_quarter | MED | Preeclampsia Research Issues. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) | 10000 | 0 | 0 | 2015-04-14T14:48:09.573000-04:00 | |
| 1660709 | WEBMD HEALTH CORP. 42c338e5-6b07-42d5-93ca-060d241dd103 | Q1 | WEBMD HEALTH CORP. | 55473 | WEBMD HEALTH CORP | 2015 | first_quarter | MED | Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records | SENATE | 10000 | 0 | 0 | 2015-04-14T15:01:41.980000-04:00 | |
| 1660877 | PARALYZED VETERANS OF AMERICA d417ca92-b3d3-4221-ae4c-a121fb78572c | Q1 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2015 | first_quarter | MED | S. 800, the Enhancing the Stature and Visibility of Medical Rehabilitation Research at the National Institutes of Health Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 64672 | 0 | 0 | 2015-04-14T15:44:14.380000-04:00 | |
| 1660925 | THE CORMAC GROUP, LLC 85de51dc-7e5b-4132-bead-1496bfc15cb8 | Q1 | THE CORMAC GROUP, LLC | 66773 | HTG MOLECULAR DIAGNOSTICS, INC. | 2015 | first_quarter | MED | Medicare high end technology reimbursement issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-14T16:02:55.953000-04:00 | |
| 1660961 | THE CORMAC GROUP, LLC 58122977-0e5e-4201-b4e6-1f7d6cd639b8 | Q1 | THE CORMAC GROUP, LLC | 66773 | AMERICAN CAPITOL GROUP, LLC | 2015 | first_quarter | MED | FDA reform and 21st Century Cures initiative on behalf of My Life is Worth It (MLIWI) | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-14T16:15:26.487000-04:00 | |
| 1661021 | THE CORMAC GROUP, LLC 88f2e49c-d125-43d5-abfc-59cce1d0b03b | Q1 | THE CORMAC GROUP, LLC | 66773 | SBIOMED | 2015 | first_quarter | MED | President's Interagency Task Force on Fighting Antibiotic Resistant Bacteria | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-14T16:45:12.623000-04:00 | |
| 1661041 | THE CORMAC GROUP, LLC 335b4373-e6e5-4299-ab85-ae8a3a9d70fd | Q1 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2015 | first_quarter | MED | Appropriations, DOD, TBI Research, Veterans Issues | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-14T17:03:29.023000-04:00 | |
| 1661044 | THE CORMAC GROUP, LLC be4003e9-4e30-4fdb-8183-af5e7f618841 | 1A | THE CORMAC GROUP, LLC | 66773 | SBIOMED | 2015 | first_quarter | MED | President's Interagency Task Force on Fighting Antibiotic Resistant Bacteria | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-14T17:06:32.457000-04:00 | |
| 1661098 | UNIVERSITY OF IOWA c1618be2-6c56-47bb-b2e5-0fcad8321906 | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2015 | first_quarter | MED | Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and Safety FY 2015 Appropriations Prevention Research Centers Resident Physician Shortage Health Care Reform FY 2014 Appropriations FY 2015 Appropriations | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT) | 86662 | 0 | 0 | 2015-04-14T17:12:41.713000-04:00 | |
| 1661161 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 0969ec50-dd41-40b3-909c-e14d24369a0c | Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | METABIOTA | 2015 | first_quarter | MED | Public health, public health funding, global health | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-14T18:19:09.153000-04:00 | |
| 1661217 | BROYDRICK & ASSOCIATES 96458263-f19c-4781-91bb-87a68970c1e6 | Q1 | BROYDRICK & ASSOCIATES | 7268 | EXACT SCIENCES | 2015 | first_quarter | MED | 21st century Cures project. Approval for cancer screening test. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2015-04-14T20:47:59.607000-04:00 | |
| 1661230 | BROYDRICK & ASSOCIATES f9c23f30-51d7-471f-b986-4d49669efb41 | Q1 | BROYDRICK & ASSOCIATES | 7268 | NORTHSTAR RADIOISOTOPES, LLC | 2015 | first_quarter | MED | DOE policies. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-14T21:11:11.610000-04:00 | |
| 1661259 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9beea7af-25f2-4ddc-84bc-368ef2428360 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2015 | first_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-15T08:24:39.677000-04:00 | |
| 1661261 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 65d6c973-83de-4e23-bd36-5ec3f831b56c | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | 23ANDME, INC. | 2015 | first_quarter | MED | Direct to consumer genetic testing No bill #, 21st Century Cures Act Regulation and oversight of diagnostics | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-15T08:35:42.223000-04:00 | |
| 1661318 | LNE GROUP 5bcdca46-60f4-48c7-8a78-18bf81cf0b32 | Q1 | LNE GROUP | 308811 | PARKER HANNIFIN | 2015 | first_quarter | MED | Lobbied for Issues Related to Medical/Disease Research/ Clinical Labs | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2015-04-15T09:20:18.123000-04:00 | |
| 1661371 | LNE GROUP ab459257-953e-43e8-854d-3b2796f4747b | 1A | LNE GROUP | 308811 | PARKER HANNIFIN | 2015 | first_quarter | MED | Lobbied for Issues Related to Medical/Disease Research/ Clinical Labs | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2015-04-15T09:36:31.883000-04:00 | |
| 1661385 | SRI INTERNATIONAL 675967b9-4edb-4a4a-b022-060e8adbe509 | Q1 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2015 | first_quarter | MED | FY16 Labor/HHS/Education Appropriations (House and Senate) 21st Century Cures Act (house bill draft) | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2015-04-15T09:42:35.770000-04:00 | |
| 1661396 | LNE GROUP 80f2f109-2a93-4477-ae62-5f334e23de63 | 1A | LNE GROUP | 308811 | SPR THERAPEUTICS | 2015 | first_quarter | MED | Lobbied for Medical/Disease Research/ and Clinical Labs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-15T09:55:45.050000-04:00 | |
| 1661741 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 46ecd4e9-d6a8-4181-bab3-44e84e4ecc22 | 1T | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | ASPEN SYSTEMS | 2015 | first_quarter | MED | Advancement of micro-compressor and personal cooling systems. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2015-04-15T12:15:08.417000-04:00 | |
| 1661764 | FAEGRE DRINKER BIDDLE & REATH LLP bdee411e-1c23-4fbe-9ded-4db37b221ac7 | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2015 | first_quarter | MED | Issues related to FDA priority review voucher and other drug development incentives; 21st Century Cures draft, provisions related to priority review vouchers. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-15T12:23:27.457000-04:00 | |
| 1661784 | FAEGRE DRINKER BIDDLE & REATH LLP 5eeebc77-b570-4303-8022-2347d1a4b8fe | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | ALLIANCE FOR BIOSECURITY | 2015 | first_quarter | MED | BioShield Project; Biomedical Countermeasures; Biodefense Research and Development Authority; Pandemic and All-Hazards Preparedness Reauthorization (H.R. 2405 and the Public Law). | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 70000 | 0 | 0 | 2015-04-15T12:26:39.767000-04:00 | |
| 1661801 | FAEGRE DRINKER BIDDLE & REATH LLP 657a5d28-0db0-4921-b88b-5c6dd741b560 | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2015 | first_quarter | MED | Public Health Programs for Infectious and Tropical Disease; Department of Defense Tropical Medicine Research; 21st Century Cures draft legislation issues related to Government Agency Conference Attendance Policy. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-15T12:31:52.743000-04:00 | |
| 1661815 | FAEGRE DRINKER BIDDLE & REATH LLP 1bb8ced0-74e1-4974-ab15-b03592474daf | 1T | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | ADULT CONGENITAL HEART ASSOCIATION | 2015 | first_quarter | MED | Reauthorization of Congential Hearts Future Act. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 1 | 2015-04-15T12:34:01.380000-04:00 | ||
| 1662047 | WITT O'BRIEN'S, LLC (F/K/A WITT GROUP HOLDINGS, LLC) 41ecbc07-c5ec-4758-882e-a717896b9a4c | Q1 | WITT O'BRIEN'S, LLC (F/K/A WITT GROUP HOLDINGS, LLC) | 76491 | INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS | 2015 | first_quarter | MED | FDA oversight issues; password issues | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2015-04-15T14:07:37.240000-04:00 | ||
| 1662097 | CAPITOL HILL STRATEGIES, LLC 516fa10b-c642-476b-abea-ce625316f6a1 | Q1 | CAPITOL HILL STRATEGIES, LLC | 91774 | BIOGEN INC | 2015 | first_quarter | MED | S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2015-04-15T14:15:00.010000-04:00 | |
| 1662122 | CAPITOL HILL STRATEGIES, LLC feb686f2-eb89-49c8-8e86-648706e18d65 | Q1 | CAPITOL HILL STRATEGIES, LLC | 91774 | MERCK & CO., INC | 2015 | first_quarter | MED | Draft 21st Century Cures legislation under consideration by the House Energy & Commerce Committee (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies) | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-15T14:22:16.297000-04:00 | |
| 1662141 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c3b268e8-2180-46bb-b74d-85e5660a4eab | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2015 | first_quarter | MED | No HR#/No S#, Labor-HHS-Education Appropriations bill, FY 2016, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. No bill #, Defense Appropriations, FY 2016 defense health programs, Tuberous Sclerosis Complex Research Program. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2015-04-15T14:27:29.900000-04:00 | |
| 1662180 | CAPITOL HILL STRATEGIES, LLC 603a4da2-cd77-456e-8889-ef1198afc004 | Q1 | CAPITOL HILL STRATEGIES, LLC | 91774 | PHRMA | 2015 | first_quarter | MED | Draft 21st Century Cures legislation under consideration by the House Energy & Commerce Committee (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies) S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2015-04-15T14:34:46.610000-04:00 | |
| 1662362 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 54e1a828-2984-45a2-ad91-b30ea1f450cd | 1A | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2015 | first_quarter | MED | Precision Medicine Initiative | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 50000 | 0 | 0 | 2015-04-15T15:30:44.917000-04:00 | |
| 1662565 | CARLIN COMMUNICATIONS 33c5e51e-9407-40cc-8599-4f80fb5841e9 | Q1 | CARLIN COMMUNICATIONS | 401103172 | BAVARIAN NORDIC A/S | 2015 | first_quarter | MED | Medical preparedness, funding for Biomedical Advanced Research and Development Authority, funding for Bioshield | HOUSE OF REPRESENTATIVES,SENATE | 10500 | 0 | 0 | 2015-04-15T16:51:12.327000-04:00 | |
| 1662935 | VAN SCOYOC ASSOCIATES 3f5755b9-d131-4dc9-89b7-8a47b44fc9dc | Q1 | VAN SCOYOC ASSOCIATES | 39837 | H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL, INC. | 2015 | first_quarter | MED | 21st Century Cures Act, Cancer research and development issues. Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2016, Cancer research and development issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-16T06:26:36.987000-04:00 | |
| 1662948 | VAN SCOYOC ASSOCIATES 8c05f2e2-7493-49cd-8f35-835ebe6242c3 | Q1 | VAN SCOYOC ASSOCIATES | 39837 | NOVEOME BIOTHERAPEUTICS INC | 2015 | first_quarter | MED | Food and Drug Administration regulatory matters, generally. 21st Century Cures Act, Medical research and development issues. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2015-04-16T06:31:40.560000-04:00 | |
| 1663080 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e73f77db-eb90-4758-b2d2-68177edfbc10 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2015 | first_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2015-04-16T08:50:53.113000-04:00 | |
| 1663087 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f45a8dcd-a6f6-4df2-8c3b-31498ee87307 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2015 | first_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2015-04-16T08:53:54.377000-04:00 | |
| 1663098 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa2fd725-fefd-4641-bd11-5c6936cd7120 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2015 | first_quarter | MED | Research in hematology | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2015-04-16T08:57:58.373000-04:00 | |
| 1663129 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. dadbe0b9-10d1-43b4-b082-85a9026b8d82 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2015 | first_quarter | MED | Research in Endocrinology; House 21st Century Cures bill; Senate Innovations for Healthier Americans bill; Sex Differences in research. | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2015-04-16T09:17:12.697000-04:00 | |
| 1663294 | THORN RUN PARTNERS 92c8b358-bcc8-48c8-bc95-ca34c0294671 | Q1 | THORN RUN PARTNERS | 400534596 | CONTINUING MEDICAL EDUCATION COALITION | 2015 | first_quarter | MED | H.R.293, Protect Continuing Physician Education and Patient Care Act. Issues related to the promotion of continuing medical education and the implementation of the Physician Payment Sunshine Act. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2015-04-16T10:06:42.410000-04:00 | |
| 1663370 | THORN RUN PARTNERS 1485c5fe-4805-4d55-85ac-ab9e306c20e1 | Q1 | THORN RUN PARTNERS | 400534596 | NOVARTIS CORPORATION | 2015 | first_quarter | MED | Issues related to biologics. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-16T10:31:28.680000-04:00 | |
| 1663584 | THORN RUN PARTNERS d0409799-38c8-4a54-9d18-7892ac3a5678 | Q1 | THORN RUN PARTNERS | 400534596 | CHILDRENS HOSPITAL COLORADO | 2015 | first_quarter | MED | Issues related to pediatric research and childrens hospital graduate medical education. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-16T11:08:20.763000-04:00 | |
| 1663592 | THORN RUN PARTNERS 320b3dd8-6253-43d8-afca-ee762a3ff731 | Q1 | THORN RUN PARTNERS | 400534596 | ABBVIE INC. | 2015 | first_quarter | MED | Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-16T11:10:28.837000-04:00 | |
| 1663611 | THORN RUN PARTNERS 1011cec5-1206-4dc3-8a7b-807c67043b86 | Q1 | THORN RUN PARTNERS | 400534596 | ABBOTT LABORATORIES | 2015 | first_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2015-04-16T11:11:38.147000-04:00 | |
| 1663640 | STANFORD UNIVERSITY 2b3dbd77-c96e-4eac-b0f8-96809d260556 | Q1 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2015 | first_quarter | MED | Health Professional Programs Graduate Medical Education Funding HR1117 Creating Access to Residency Education Act | Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE | 70000 | 0 | 0 | 2015-04-16T11:19:01.497000-04:00 | |
| 1663791 | WASHINGTON STATE UNIVERSITY 2284e8ae-36bc-4fd8-b7d5-3b3c97798d0a | Q1 | WASHINGTON STATE UNIVERSITY | 40657 | WASHINGTON STATE UNIVERSITY | 2015 | first_quarter | MED | Health Science Campus, Research Development, Paul G Allen School for Global Health (CDHAM)(Uniformed Services University), Antibiotic Resistance Issues, 21st Century Cures--Roundtable discussion of streamlining FDA approval process for drugs and devices, Graduate Medical Education | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 120000 | 0 | 0 | 2015-04-16T11:43:20.580000-04:00 | |
| 1663814 | NORTHWESTERN UNIV 31231d23-bb02-4af0-8713-a5041d702b90 | Q1 | NORTHWESTERN UNIV | 299992 | NORTHWESTERN UNIV | 2015 | first_quarter | MED | S. 289, American Cures Act, entire bill. S. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill. | HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 0 | 2015-04-16T11:47:39.277000-04:00 | |
| 1663880 | THORN RUN PARTNERS 78a6a85f-4c09-4109-9219-dc8fc718b4c2 | Q1 | THORN RUN PARTNERS | 400534596 | HACKENSACK MERIDIAN HEALTH | 2015 | first_quarter | MED | Issues relating to research funding, NIH and other matters. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-16T12:07:25.803000-04:00 | |
| 1664164 | MCDERMOTT WILL & SCHULTE LLP 2f7f9c08-55d2-4c2d-b59c-7db814151308 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION | 2015 | first_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 0 | 0 | 2015-04-16T13:10:56.743000-04:00 | ||
| 1664180 | MCDERMOTT WILL & SCHULTE LLP 41e65262-2b1f-46c0-99e5-55cdc06d089b | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | COALITION FOR 21ST CENTURY MEDICINE | 2015 | first_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 0 | 0 | 2015-04-16T13:17:04.787000-04:00 | ||
| 1664453 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 391b5f71-4f67-439e-ad9a-6c86e04b45d9 | Q1 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2015 | first_quarter | MED | Support for medical research at the National Institutes of Health and National Eye Institute; Support for medical research at the Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 63255 | 0 | 0 | 2015-04-16T14:18:23.977000-04:00 | |
| 1664509 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION da334a38-6c9f-46d1-bf26-0aadcb328d2e | Q1 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 401103605 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 2015 | first_quarter | MED | HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2015-04-16T14:29:52.107000-04:00 | |
| 1664560 | MYRIAD GENETIC LABORATORIES, INC. a969f309-0cad-4cf2-a5ad-3a67183384ce | Q1 | MYRIAD GENETIC LABORATORIES, INC. | 400821434 | MYRIAD GENETIC LABORATORIES, INC. | 2015 | first_quarter | MED | FDA draft guidance to regulate laboratory developed tests and companion diagnostics 21st Century Cures Discussion Draft; Legislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2015-04-16T14:45:26.727000-04:00 | |
| 1664706 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 66dbc08d-02a0-4b54-90a2-cf5f9e22ad3e | Q1 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | 401103415 | CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. | 2015 | first_quarter | MED | Implementation of the National Research Pediatric Research Act, all provisions; 21st Century Cures Act, provisions related to the National Research Pediatric Research Act and ACE Kids Act; 340B Program, continuation of eligibility for childrens hospitals | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2015-04-16T15:13:39.147000-04:00 | |
| 1665234 | CHAMBER HILL STRATEGIES 4844d641-112d-4b63-9533-9435b0d05e8f | Q1 | CHAMBER HILL STRATEGIES | 400645947 | SANFORD HEALTH | 2015 | first_quarter | MED | Issues related to Ebola outbreak including education, research and funding for medical therapeutic development. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2015-04-16T17:49:00.700000-04:00 | |
| 1665493 | VAN SCOYOC ASSOCIATES 9fac7e2a-9e2e-452e-8f9f-ec5e1771e8c7 | Q1 | VAN SCOYOC ASSOCIATES | 39837 | MEDICAL UNIVERSITY HOSPITAL AUTHORITY | 2015 | first_quarter | MED | Medical research and development related issues: National Institutes of Health, and various institutes and bureaus thereof Health Resources Services Administration Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-17T05:12:05.247000-04:00 | |
| 1665639 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bf6779c4-de91-439c-935a-819558dda6a6 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PHELAN-MCDERMID SYNDROME FOUNDATION | 2015 | first_quarter | MED | FY 2016 Labor-HHS-Education Appropriations FY 2016 Defense Appropriations NIH research on Phelan-McDermid Syndrome | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2015-04-17T08:49:08.197000-04:00 | ||
| 1665694 | SMITHS GROUP SERVICES CORPORATION 39a90c15-7667-4531-ad8c-9b8f45aa7b25 | Q1 | SMITHS GROUP SERVICES CORPORATION | 290137 | SMITHS GROUP SERVICES CORPORATION | 2015 | first_quarter | MED | H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; issues related to patient infusion therapy. | Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Guard,SENATE,Transportation Security Administration (TSA),U.S. Customs & Border Protection | 560000 | 0 | 0 | 2015-04-17T09:11:40.140000-04:00 | |
| 1665790 | RAMPY NORTHRUP LLC b43cb08a-989c-4250-a58f-96b479ddceaa | Q1 | RAMPY NORTHRUP LLC | 401103289 | AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) | 2015 | first_quarter | MED | Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services). Proposals concerning the Stark Law's in-office ancillary services exception. Policies impacting Medicare reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. H.R.2, Medicare Access and CHIP Reauthorization Act of 2015. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2015-04-17T09:34:34.770000-04:00 | |
| 1665899 | AMERICAN ASSOCIATION FOR CANCER RESEARCH a171df15-bb04-4ed4-8bfe-f9a3e202da64 | Q1 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 400601833 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 2015 | first_quarter | MED | 21st Century Cures Initiatiave and Innovation for Healthier Americans Initiative | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-04-17T09:57:53.197000-04:00 | |
| 1665983 | BAKER BOTTS, L.L.P. 3898b884-15b6-4081-b64f-347beb94c796 | Q1 | BAKER BOTTS, L.L.P. | 5118 | SOUTHERN METHODIST UNIVERSITY | 2015 | first_quarter | MED | Funding of neurophotonics research for prosthetic devices and research into detecting traumatic brain injury. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 20000 | 0 | 0 | 2015-04-17T10:10:49.040000-04:00 | |
| 1666019 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) bb979579-c8e9-4ec9-bf11-4f0b6acec962 | Q1 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. | 2015 | first_quarter | MED | Advocacy on behalf of gender equity in medical research, preventative health care; reproductive health, affordable, high-quality child care, women's economic equity and strengthening efforts to fight human trafficking. | 10000 | 0 | 0 | 2015-04-17T10:13:03.990000-04:00 | ||
| 1666086 | AMERICAN ACADEMY OF PEDIATRICS 3fbfbd18-c3cf-4a79-a970-804d4dfb438f | Q1 | AMERICAN ACADEMY OF PEDIATRICS | 1397 | AMERICAN ACADEMY OF PEDIATRICS | 2015 | first_quarter | MED | Medical/disease research funding (NIH, CDC, HRSA) | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Indian Health Service,Natl Highway Traffic Safety Administration (NHTSA),Office of Management & Budget (OMB),SENATE,White House Office | 157899 | 0 | 0 | 2015-04-17T10:24:38.287000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);